Medical adviser: issue 93
Dr Bob Phillips, Senior Academic Consultant at University of York, Consultant Paediatric Oncologist at Leeds Children’s Hospital and CCLG member, writes...
Dr Bob Phillips, Senior Academic Consultant at University of York, Consultant Paediatric Oncologist at Leeds Children’s Hospital and CCLG member, writes...
Imaging is central to diagnosing and monitoring solid cancers and scans are a key part of the patient and family journey. Different types of scans such as CT, MRI and PET, have all become commonplace in hospitals throughout the UK and children benefit from the accurate high-quality images they produce.
Naomi Shefford-Thomas, CCLG Information Executive and mum to Phoebe, who underwent almost four years of treatment for neuroblastoma, answers your questions.
Dr Annmarie Jeanes, Consultant Paediatric Radiologist at Leeds Children’s Hospital, explains the different types of imaging your child may experience at the time of diagnosis, during treatment and follow-up
Brad Gudger, diagnosed with leukaemia as a 19-year-old, tells us how he has used his own experiences to establish a charity and launch an app for cancer patients aged 18+.
The clinical lead nurse at Bristol Haematology and Oncology Centre and Chair of TYAC talks to us about his career, plans and interests.
Adapting to life after treatment can be difficult, and patients and their families may experience a range of different emotions as a result.
Chloe Hunt was diagnosed with neuroblastoma in 2010. She describes the challenges she faced adapting to a ‘new normal’ both during and after treatment, and how she overcame them.
This year, a new cancer statistics report for children, teenagers and young adults was published. This is the first report for almost a decade covering the whole of the UK and the first that covers both children’s and teenage and young adult cancers. With input from CCLG professional members, the report was shared at our Winter Meeting in February, and will help us to understand progress in the management of these cancers. Here are some key figures from the report: